SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-016213
Filing Date
2022-04-27
Accepted
2022-04-27 16:02:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA 14A brhc10036843_defa14a.htm DEFA14A 12097
2 image001.jpg GRAPHIC 120733
3 image002.jpg GRAPHIC 69153
  Complete submission text file 0001140361-22-016213.txt   274815
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39279 | Film No.: 22859446
SIC: 2836 Biological Products, (No Diagnostic Substances)